About Cellfield
Cellfield Pty Ltd is an Australian company, based in Southport Queensland, whose registered address is in Sydney. It was incorporated in March 2001 to deliver the innovative Cellfield treatment for severe reading disorders.
The Chairman of Cellfield is Australian Robert Sauer, who is also a lawyer in a Sydney law firm. He has had a long career in innovation, serving on the boards of several innovation based companies and serving on the Industrial Research and Development Board of the Australian Government.
The Cellfield CEO is Dimitri Caplygin, who is also the inventor. Dimitri came to Australia in 1950 as a refugee from Russia.
Dimitri was moved by the widespread suffering of dyslexics and was bewildered by the positions of exclusivity taken by many scientists as to the causes of dyslexia. With the fresh eyes of an outsider, Dimitri thought their positions were largely not contradictory, but part of a continuum of causes that could be tied together through computer science.
Dimitri lodged provision patent applications in 1999 for the Cellfield treatment. It took a further two years to find the seed capital required to conduct a pilot trial, which was completed in 2001. The first Clinic in Queensland was opened early in 2002.
|
